NEUVOGEN Trademark

Trademark Overview

On Wednesday, March 25, 2020, a trademark application was filed for NEUVOGEN with the United States Patent and Trademark Office. The USPTO has given the NEUVOGEN trademark a serial number of 88985509. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Tuesday, February 10, 2026. This trademark is owned by ImmunoActiva, Inc.. The NEUVOGEN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of vaccines and medicines
neuvogen

General Information

Serial Number88985509
Word MarkNEUVOGEN
Filing DateWednesday, March 25, 2020
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateTuesday, February 10, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 31, 2024

Trademark Statements

Goods and ServicesResearch and development of vaccines and medicines

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 31, 2020
Primary Code042
First Use Anywhere DateSaturday, August 1, 2020
First Use In Commerce DateSaturday, August 1, 2020

Trademark Owner History

Party NameNEUVOGEN, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92121
Party NameNEUVOGEN, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92121
Party NameImmunoActiva, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Saturday, March 28, 2020NEW APPLICATION ENTERED
Tuesday, March 31, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 16, 2020ASSIGNED TO EXAMINER
Tuesday, June 16, 2020NON-FINAL ACTION WRITTEN
Tuesday, June 16, 2020NON-FINAL ACTION E-MAILED
Tuesday, June 16, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, July 1, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, November 23, 2020SUSPENSION LETTER WRITTEN
Monday, November 23, 2020LETTER OF SUSPENSION E-MAILED
Monday, November 23, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sunday, May 23, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, November 24, 2021SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, December 20, 2021NON-FINAL ACTION WRITTEN
Monday, December 20, 2021NON-FINAL ACTION E-MAILED
Monday, December 20, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 14, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 14, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 15, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 16, 2022SUSPENSION LETTER WRITTEN
Thursday, June 16, 2022LETTER OF SUSPENSION E-MAILED
Thursday, June 16, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, December 21, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, July 13, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, July 18, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Saturday, January 27, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, September 5, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, November 14, 2024ASSIGNED TO LIE
Thursday, November 14, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 14, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 6, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 25, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 31, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 31, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 25, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 18, 2025TEAS STATEMENT OF USE RECEIVED
Monday, August 18, 2025TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, January 27, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 18, 2025DIVISIONAL REQUEST RECEIVED
Monday, February 9, 2026DIVISIONAL PROCESSING COMPLETE
Monday, August 18, 2025USE AMENDMENT FILED
Monday, February 9, 2026STATEMENT OF USE PROCESSING COMPLETE
Tuesday, February 10, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 10, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

neuvogen medicines vaccines development research